Aug 11, 2025 04:04PM

Jul 21, 2025 07:00AM

Jul 21, 2025 07:00AM

Jul 1, 2025 04:01PM

Jul 1, 2025 04:01PM

May 20, 2025 04:01PM

May 20, 2025 04:01PM Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody

May 14, 2025 04:15PM

Mar 7, 2025 08:30AM

Mar 6, 2025 04:09PM

Dec 19, 2024 07:00AM

Nov 14, 2024 06:38AM

64,524 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All